340B Advocacy Alliance Bulletin
Responding to AHA and other health care groups’
The AHA and five other health care organizations today sent a letter to Health and Human Services Secretary Xavier Becerra urging him to stop the actions of six drug companies that are denying 340B discounts on prescription drugs sold to hospitals treating a large percentage of low-income and rural…
The AHA today urged the Department of Health and Human Services to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have access to the program despite changes in their payer mix as a result of the COVID-19 public health emergency.
The AHA yesterday
Replay of Available of Feb.
340B Advocacy Alliance Bulletin: Last Chance to Register for Today’s 340B Alliance Call at 3 p.m. ET
The AHA 340B Advocacy Alliance today, Feb. 22 at 3 p.m. ET will provide an update on the many legal cases and issues surrounding the 340B drug savings program. This call is for AHA members only, and you must register for the call in order to participate.
A U.S.
The AHA 340B Advocacy Alliance Feb. 22 at 3 p.m. ET will provide an update on the many legal cases and issues surrounding the 340B Drug Pricing Program.
The AHA, joined by member hospitals and health systems and other national organizations representing hospitals, yesterday filed petitions asking the U.S. Supreme Court to reverse appeals court decisions in two important cases for patients and providers.
The two cases being appealed to the U.S.…
Please contact your representatives and ask them to sign onto a